dc.contributor.author |
Lerche, Holger |
|
dc.contributor.author |
Krüger, Johanna |
|
dc.date.accessioned |
2025-03-31T06:18:31Z |
|
dc.date.available |
2025-03-31T06:18:31Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
0028-3908 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/163376 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Oxford : Pergamon - Elsevier Science Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.neuropharm.2024.109892 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Retigabine and gabapentin restore channel function and neuronal firing in a cellular model of an epilepsy-associated dominant-negative KCNQ5 variant |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20241001000000_02264 |
|
utue.personen.roh |
Krueger, Johanna |
|
utue.personen.roh |
Lerche, Holger |
|
dcterms.isPartOf.ZSTitelID |
Neuropharmacology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 109892 |
de_DE |
dcterms.isPartOf.ZS-Volume |
250 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |